Intravitreal anti-vascular endothelial growth factor therapy with pegaptanib for advanced von Hippel-Lindau disease of the retina.

Source:http://linkedlifedata.com/resource/pubmed/id/17290195

Download in:

View as

General Info

PMID
17290195